User profiles for Fabienne Brilot
 | Fabienne BrilotUniversity of Sydney Verified email at sydney.edu.au Cited by 9741 |
Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: International MOGAD Panel proposed criteria
…, JL Bennett, R Marignier, HJ Kim, F Brilot… - The Lancet …, 2023 - thelancet.com
Serum antibodies directed against myelin oligodendrocyte glycoprotein (MOG) are found in
patients with acquired CNS demyelinating syndromes that are distinct from multiple sclerosis …
patients with acquired CNS demyelinating syndromes that are distinct from multiple sclerosis …
Myelin-oligodendrocyte glycoprotein antibody-associated disease
Myelin-oligodendrocyte glycoprotein antibody-associated disease (MOGAD) is a recently
identified autoimmune disorder that presents in both adults and children as CNS demyelination…
identified autoimmune disorder that presents in both adults and children as CNS demyelination…
Clinical course, therapeutic responses and outcomes in relapsing MOG antibody-associated demyelination
…, MH Barnett, SW Reddel, F Brilot… - Journal of Neurology …, 2018 - jnnp.bmj.com
Objective We characterised the clinical course, treatment and outcomes in 59 patients with
relapsing myelin oligodendrocyte glycoprotein (MOG) antibody-associated demyelination. …
relapsing myelin oligodendrocyte glycoprotein (MOG) antibody-associated demyelination. …
Antibodies to surface dopamine-2 receptor in autoimmune movement and psychiatric disorders
Recent reports of autoantibodies that bind to neuronal surface receptors or synaptic proteins
have defined treatable forms of autoimmune encephalitis. Despite these developments, …
have defined treatable forms of autoimmune encephalitis. Despite these developments, …
[HTML][HTML] Maternal acute and chronic inflammation in pregnancy is associated with common neurodevelopmental disorders: a systematic review
Inflammation is increasingly recognized as a cause or consequence of common problems
of humanity including obesity, stress, depression, pollution and disease states such as …
of humanity including obesity, stress, depression, pollution and disease states such as …
Antibodies to native myelin oligodendrocyte glycoprotein in children with inflammatory demyelinating central nervous system disease
Objective Myelin oligodendrocyte glycoprotein (MOG) is a candidate target antigen in
demyelinating diseases of the central nervous system (CNS). Although MOG is encephalitogenic …
demyelinating diseases of the central nervous system (CNS). Although MOG is encephalitogenic …
Utility and safety of rituximab in pediatric autoimmune and inflammatory CNS disease
Objective: To assess the utility and safety of rituximab in pediatric autoimmune and inflammatory
disorders of the CNS. Methods: Multicenter retrospective study. Results: A total of 144 …
disorders of the CNS. Methods: Multicenter retrospective study. Results: A total of 144 …
Radiological differentiation of optic neuritis with myelin oligodendrocyte glycoprotein antibodies, aquaporin-4 antibodies, and multiple sclerosis
Background: Recognizing the cause of optic neuritis (ON) affects treatment decisions and
visual outcomes. Objective: We aimed to define radiological features of first-episode …
visual outcomes. Objective: We aimed to define radiological features of first-episode …
Anti-MOG antibody: the history, clinical phenotype, and pathogenicity of a serum biomarker for demyelination
Myelin oligodendrocyte glycoprotein (MOG) is a protein exclusively expressed on the surface
of oligodendrocytes and myelin in the central nervous system. MOG has been identified as …
of oligodendrocytes and myelin in the central nervous system. MOG has been identified as …
N‐methyl‐D‐aspartate receptor antibodies in pediatric dyskinetic encephalitis lethargica
Encephalitis lethargica (EL) describes an encephalitis with psychiatric, sleep, and extrapyramidal
movement disorders. Dyskinetic and Parkinsonian forms have been described. EL …
movement disorders. Dyskinetic and Parkinsonian forms have been described. EL …